These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 7544327)

  • 1. Risk, autonomy, and responsibility. Informed consent for prenatal testing.
    Press N; Browner CH
    Hastings Cent Rep; 1995; 25(3):S9-12. PubMed ID: 7544327
    [No Abstract]   [Full Text] [Related]  

  • 2. Prenatal screening for neural tube defects.
    Holtzman NA
    Pediatrics; 1983 Apr; 71(4):658-60. PubMed ID: 6188096
    [No Abstract]   [Full Text] [Related]  

  • 3. Risk, autonomy, and responsibility: informed consent for prenatal testing.
    Press N; Browner CH
    Hastings Cent Rep; 1995; 25(3 Suppl):S9-12. PubMed ID: 11654189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Open neural tube defects in prenatal diagnosis].
    Zaremba J; Roszkowski T; Szirkowiec W
    Przegl Lek; 1998; 55(4):159-63. PubMed ID: 9656739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current status of alpha-fetoprotein testing.
    Macri JN
    Clin Lab Med; 1981 Jun; 1(2):181-98. PubMed ID: 6179687
    [No Abstract]   [Full Text] [Related]  

  • 6. In California, voluntary mass prenatal screening.
    Steinbrook R
    Hastings Cent Rep; 1986 Oct; 16(5):5-7. PubMed ID: 2429941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maternal serum screening for neural tube defects and Down syndrome.
    Keith D
    Clin Lab Sci; 1992; 5(5):274-6. PubMed ID: 10150964
    [No Abstract]   [Full Text] [Related]  

  • 8. Criticism of the California alpha fetoprotein screening program.
    Lasnover AL
    West J Med; 1987 Jan; 146(1):100. PubMed ID: 2435065
    [No Abstract]   [Full Text] [Related]  

  • 9. Maternal alpha fetoprotein screening.
    Br Med J (Clin Res Ed); 1981 Oct; 283(6298):1053-4. PubMed ID: 6170380
    [No Abstract]   [Full Text] [Related]  

  • 10. Mass screening for neural tube defects.
    Kolata GB
    Hastings Cent Rep; 1980 Dec; 10(6):8-10. PubMed ID: 6161904
    [No Abstract]   [Full Text] [Related]  

  • 11. Screening for fetal neural tube defects: rationale and experience.
    Brock DJ
    Prog Clin Biol Res; 1982; 103 Pt B():461-72. PubMed ID: 6187021
    [No Abstract]   [Full Text] [Related]  

  • 12. Screening for open neural tube defects from 21 to 25 weeks' gestation: the Manitoba experience.
    Björklund NK; MacDonald KM; Evans JA; Schneider CE; Chodirker BN
    Prenat Diagn; 2005 Aug; 25(8):715-7. PubMed ID: 16052469
    [No Abstract]   [Full Text] [Related]  

  • 13. [Alpha-fetoproteins in obstetrics].
    Weitzel H
    Gynakologe; 1983 Sep; 16(3):148-54. PubMed ID: 6196260
    [No Abstract]   [Full Text] [Related]  

  • 14. Maternal serum screening for neural tube defects and fetal chromosome abnormalities.
    Rose NC; Mennuti MT
    West J Med; 1993 Sep; 159(3):312-7. PubMed ID: 7694429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening for neural tube defects. Results in practice.
    Hibbard BM
    Midwife Health Visit Community Nurse; 1982 Nov; 18(11):460-6. PubMed ID: 6183562
    [No Abstract]   [Full Text] [Related]  

  • 16. [Prenatal screening for fetal neural-tube defects by immunodiffusion autoradiography (author's transl)].
    Zheng ZQ
    Zhonghua Fu Chan Ke Za Zhi; 1981 Oct; 16(4):209-10. PubMed ID: 6177478
    [No Abstract]   [Full Text] [Related]  

  • 17. Neural tube defects: prenatal screening.
    Sickler GK; Nyberg DA
    AJR Am J Roentgenol; 1996 Feb; 166(2):466-7. PubMed ID: 8553978
    [No Abstract]   [Full Text] [Related]  

  • 18. Recurrent false-positives in AFP screening for open neural tube defects.
    Wald NJ; Huttly WJ; Rudnicka AR
    Prenat Diagn; 2004 Dec; 24(12):1018-9. PubMed ID: 15614882
    [No Abstract]   [Full Text] [Related]  

  • 19. [Prenatal serum screening of aneuploidy and of neural tube defects in the second trimester of pregnancy among the population of Luxembourg. Evaluation of risk by the triple test (AFP+THCG+UE3)].
    Thix J
    Bull Soc Sci Med Grand Duche Luxemb; 1997; 134(1):25-9. PubMed ID: 9303823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prenatal screening tests facilitate risk assessment.
    Miller SM; Isabel JM
    MLO Med Lab Obs; 2002 Feb; 34(2):8-11, 14-6, 19; quiz 20-1. PubMed ID: 11881274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.